<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38395459</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002111</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2023-002111</ELocationID><Abstract><AbstractText Label="BACKGROUND">Multiple prolonged symptoms observed in patients who recovered from COVID-19 are defined as long COVID. Although diverse phenotypic combinations are possible, they remain unclear. This study aimed to perform a cluster analysis of long COVID in Japan and clarify the association between its characteristics and background factors and quality of life (QOL).</AbstractText><AbstractText Label="METHODS">This multicentre prospective cohort study collected various symptoms and QOL after COVID-19 from January 2020 to February 2021. This study included 935 patients aged &#x2265;18 years with COVID-19 at 26 participating medical facilities. Hierarchical cluster analysis was performed using 24 long COVID symptom at 3 months after diagnosis.</AbstractText><AbstractText Label="RESULTS">Participants were divided into the following five clusters: numerous symptoms across multiple organs (cluster 1, n=54); no or minor symptoms (cluster 2, n=546); taste and olfactory disorders (cluster 3, n=76); fatigue, psychoneurotic symptoms and dyspnoea (low prevalence of cough and sputum) (cluster 4, n=207) and fatigue and dyspnoea (high prevalence of cough and sputum) (cluster 5, n=52). Cluster 1 included elderly patients with severe symptoms, while cluster 3 included young female with mild symptoms. No significant differences were observed in the comorbidities. Cluster 1 showed the most impaired QOL, followed by clusters 4 and 5; these changes as well as the composition of symptoms were observed over 1&#x2009;year.</AbstractText><AbstractText Label="CONCLUSIONS">We identified patients with long COVID with diverse characteristics into five clusters. Future analysis of these different pathologies could result in individualised treatment of long COVID.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">The study protocol is registered at UMIN clinical trials registry (UMIN000042299).</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Fumimaro</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terai</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1118-1930</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan hidekit926@gmail.com rtakemura@keio.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keio Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Health Management, Keio University, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takemura</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan hidekit926@gmail.com rtakemura@keio.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namkoong</LastName><ForeName>Ho</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asakura</LastName><ForeName>Takanori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine (Laboratory of Bioregulatory Medicine), Kitasato University School of Pharmacy, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chubachi</LastName><ForeName>Shotaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuzawa</LastName><ForeName>Keita</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Sohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashiguchi</LastName><ForeName>Mizuha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kagyo</LastName><ForeName>Junko</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Keiyu Hospital, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiomi</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Keiyu Hospital, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minematsu</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hino Municipal Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manabe</LastName><ForeName>Tadashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukui</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funatsu</LastName><ForeName>Yohei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Hidefumi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masaki</LastName><ForeName>Katsunori</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0909-9409</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohgino</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawada</LastName><ForeName>Ichiro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Yasunori</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukunaga</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">infection control</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38395459</ArticleId><ArticleId IdType="pmc">PMC10895225</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2023-002111</ArticleId><ArticleId IdType="pii">11/1/e002111</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, et al. . Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020;382:1708&#x2013;20. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet 2020;395:497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechman K, Yates M, Mann K, et al. . Inpatient COVID-19 mortality has reduced over time: results from an observational cohort. PLOS ONE 2022;17:e0261142. 10.1371/journal.pone.0261142</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261142</ArticleId><ArticleId IdType="pmc">PMC8757902</ArticleId><ArticleId IdType="pubmed">35025917</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, et al. . Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis 2022;9:ofac060. 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022;13:1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Badier N, Zhang L, et al. . Long COVID classification: findings from a clustering analysis in the Predi-COVID cohort study. Int J Environ Res Public Health 2022;19:16018. 10.3390/ijerph192316018</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Florencio LL, et al. . Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical Co-morbidities in previously hospitalized COVID-19 survivors. Infection 2023;51:61&#x2013;9. 10.1007/s15010-022-01822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Yoshimura N, Ishizuka K, et al. . Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan. Clin Exp Med 2023;23:3663&#x2013;70. 10.1007/s10238-023-01057-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01057-6</ArticleId><ArticleId IdType="pmc">PMC10081305</ArticleId><ArticleId IdType="pubmed">37027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Shi L, Jiang Z, et al. . The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol Psychiatry 2023;28:1793&#x2013;801. 10.1038/s41380-023-01951-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-01951-1</ArticleId><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawara K, Namkoong H, Terai H, et al. . Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an Ambidirectional Multicentre cohort study: study protocol. BMJ Open Respir Res 2021;8:e001015. 10.1136/bmjresp-2021-001015</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001015</ArticleId><ArticleId IdType="pmc">PMC8628335</ArticleId><ArticleId IdType="pubmed">34836924</ArticleId></ArticleIdList></Reference><Reference><Citation>Terai H, Ishii M, Takemura R, et al. . Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study. Respir Investig 2023;61:802&#x2013;14. 10.1016/j.resinv.2023.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2023.08.008</ArticleId><ArticleId IdType="pubmed">37783167</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical management of patients with COVID-19: A guide for frontline Healthcare workers. version 2.1. n.d.
Available: https://www.mhlw.go.jp/content/000641267.pdf</Citation></Reference><Reference><Citation>Brooks R. Euroqol: the current state of play. Health Policy 1996;37:53&#x2013;72. 10.1016/0168-8510(96)00822-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(96)00822-6</ArticleId><ArticleId IdType="pubmed">10158943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JEJ, Kosinski M, Dewey JE, et al. . How to score and interpret single-item health status measures: A manual for users of the SF-8 health survey. 2001.</Citation></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361&#x2013;70. 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura T. The hospital anxiety and depression scale. Arch Psychiatr Diagn Clin Eval 1993;4:2.</Citation></Reference><Reference><Citation>McLachlan GJ. Cluster analysis and related techniques in medical research. Stat Methods Med Res 1992;1:27&#x2013;48. 10.1177/096228029200100103</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096228029200100103</ArticleId><ArticleId IdType="pubmed">1341650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, et al. . Symptom cluster analysis of long COVID-19 in patients discharged from the temporary COVID-19 hospital in Mexico city. Ther Adv Infect Dis 2022;9:20499361211069264. 10.1177/20499361211069264</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211069264</ArticleId><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Cari&#xf1;ena A, Moreno E, et al. . Post-COVID-19 functional status six-months after hospitalization. J Infect 2021;82:e31&#x2013;3. 10.1016/j.jinf.2020.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021;93:1013&#x2013;22. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, et al. . Sequelae in adults at 12 months after mild-to-moderate Coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021;11:1685&#x2013;8. 10.1002/alr.22832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun 2022;13:3528. 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et al. . Persistent fatigue following SARS-Cov-2 infection is common and independent of severity of initial infection. PLOS ONE 2020;15:e0240784. 10.1371/journal.pone.0240784</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, et al. . Comprehensive health assessment 3 months after recovery from acute Coronavirus disease 2019. Clinical Infectious Diseases 2021;73:e1089&#x2013;98. 10.1093/cid/ciaa1750</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, et al. . Post-acute COVID-19 syndrome. incidence and risk factors: A Mediterranean cohort study. J Infect 2021;82:378&#x2013;83. 10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvisi M, Ferrozzi F, Balzarini L, et al. . First report on clinical and radiological features of COVID-19 Pneumonitis in a Caucasian population: factors predicting Fibrotic evolution. Int J Infect Dis 2020;99:485&#x2013;8. 10.1016/j.ijid.2020.08.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.054</ArticleId><ArticleId IdType="pmc">PMC7443096</ArticleId><ArticleId IdType="pubmed">32841688</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-term effects of SARS-Cov-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. 10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. . Long-COVID&#x201d;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following Hospitalisation for COVID-19. Thorax 2021;76:396&#x2013;8. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Wang Y. The clinical characteristics and risk factors of severe COVID-19. Gerontology 2021;67:255&#x2013;66. 10.1159/000513400</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513400</ArticleId><ArticleId IdType="pmc">PMC7900480</ArticleId><ArticleId IdType="pubmed">33406518</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E, Green I, Shpigelman M, et al. . Haemoglobin A1C is a Predictor of COVID-19 severity in patients with diabetes. Diabetes Metab Res Rev 2021;37:e3398. 10.1002/dmrr.3398</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3398</ArticleId><ArticleId IdType="pmc">PMC7460936</ArticleId><ArticleId IdType="pubmed">32852883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, et al. . Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil 2022;101:48&#x2013;52. 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>McFann K, Baxter BA, LaVergne SM, et al. . Quality of life (Qol) is reduced in those with severe COVID-19 disease, post-acute sequelae of COVID-19, and hospitalization in United States adults from northern Colorado. Int J Environ Res Public Health 2021;18:11048. 10.3390/ijerph182111048</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182111048</ArticleId><ArticleId IdType="pmc">PMC8582735</ArticleId><ArticleId IdType="pubmed">34769566</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoto W, Yamada K, Kawai R, et al. . A cross-sectional, multicenter survey of the prevalence and risk factors for long COVID. Sci Rep 2022;12:22413. 10.1038/s41598-022-25398-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25398-6</ArticleId><ArticleId IdType="pmc">PMC9793373</ArticleId><ArticleId IdType="pubmed">36575200</ArticleId></ArticleIdList></Reference><Reference><Citation>OfNS . Technical article: updated estimates of the prevalence of post-acute symptoms among people with Coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. ONS Website, technical article ;1:1-2. 2022.</Citation></Reference><Reference><Citation>Yelin D, Margalit I, Nehme M, et al. . Patterns of long COVID symptoms: A multi-center cross sectional study. J Clin Med 2022;11:898. 10.3390/jcm11040898</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11040898</ArticleId><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="pubmed">35207171</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrvini B, Prajapati DP, Said M, et al. . Risk factors and characteristics associated with persistent smell loss in Coronavirus disease 2019 (COVID-19) patients. Int Forum Allergy Rhinol 2021;11:1280&#x2013;2. 10.1002/alr.22802</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22802</ArticleId><ArticleId IdType="pmc">PMC8251222</ArticleId><ArticleId IdType="pubmed">33864717</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter AL, Henecke S, Lundstr&#xf6;m JN, et al. . Impairment of quality of life due to COVID-19-induced long-term olfactory dysfunction. Front Psychol 2023;14:1165911. 10.3389/fpsyg.2023.1165911</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2023.1165911</ArticleId><ArticleId IdType="pmc">PMC10157159</ArticleId><ArticleId IdType="pubmed">37151341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Gessa C, Deiana G, et al. . n.d. The effects of persistent olfactory and Gustatory dysfunctions on quality of life in long-COVID-19 patients. Life;12:141. 10.3390/life12020141</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020141</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="pubmed">35207429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W, Robbins RT. Cluster analysis of Longidorus species (Nematoda: Longidoridae), a new approach in species identification. J Nematol 2004;36:207&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2620778</ArticleId><ArticleId IdType="pubmed">19262809</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 2021;398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Porcher R, Pane I, et al. . Course of post COVID-19 disease symptoms over time in the compare long COVID prospective E-cohort. Nat Commun 2022;13:1812. 10.1038/s41467-022-29513-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis 2023;23:393&#x2013;5. 10.1016/S1473-3099(23)00053-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B, Wills M, Sithole N. Long COVID: what is known and what gaps need to be addressed. Br Med Bull 2023;147:6&#x2013;19. 10.1093/bmb/ldad016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldad016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, et al. . SARS-Cov-2 infection in Hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med 2022;14:eabq3059. 10.1126/scitranslmed.abq3059</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, et al. . Long-COVID symptoms in individuals infected with different SARS-Cov-2 variants of concern: A systematic review of the literature. Viruses 2022;14:2629. 10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-Cov-2 infection in UK users of the COVID symptom study App: a prospective, community-based, nested, case-control study. Lancet Infect Dis 2022;22:43&#x2013;55. 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawara K, Morita A, Namkoong H, et al. . Longitudinal long COVID symptoms in Japanese patients after COVID-19 Vaccinations. Vaccine X 2023;15:100381. 10.1016/j.jvacx.2023.100381</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2023.100381</ArticleId><ArticleId IdType="pmc">PMC10507639</ArticleId><ArticleId IdType="pubmed">37731516</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>